These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. RDC endogenous depression as a predictor of response to antidepressant drugs and psychotherapy. Klerman GL; Weissman MM; Prusoff BA Adv Biochem Psychopharmacol; 1982; 32():165-74. PubMed ID: 7090892 [No Abstract] [Full Text] [Related]
5. Clinical significance, evaluation, and management of secondary depression in schizophrenia. Becker RE; Singh MM; Meisler N; Shillcutt S J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):26-32. PubMed ID: 2865254 [TBL] [Abstract][Full Text] [Related]
6. Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients. Czobor P; Volavka J J Clin Psychopharmacol; 1993 Oct; 13(5):332-42. PubMed ID: 7693770 [TBL] [Abstract][Full Text] [Related]
7. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373 [TBL] [Abstract][Full Text] [Related]
8. Schizophrenic patients before and after HIV infection: a case-control study. Mauri MC; Fabiano L; Bravin S; Ricci C; Invernizzi G Encephale; 1997; 23(6):437-41. PubMed ID: 9488926 [TBL] [Abstract][Full Text] [Related]
9. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia. Abuzzahab FS; Zimmerman RL J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757 [TBL] [Abstract][Full Text] [Related]
10. [Psychopathologic changes during 20 days of antidepressive or neuroleptic therapy]. Woggon B Psychiatr Clin (Basel); 1980; 13(3-4):150-64. PubMed ID: 6113620 [TBL] [Abstract][Full Text] [Related]
11. [Clinical use of the dexamethasone suppression test]. De Leo D; Capodieci S Minerva Psichiatr; 1984; 25(2):115-25. PubMed ID: 6436632 [No Abstract] [Full Text] [Related]
12. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial]. Shiloh R; Weizman A; Weizer N; Dorfman-Etrog P; Munitz H Harefuah; 2001 May; 140(5):369-73, 456. PubMed ID: 11419053 [TBL] [Abstract][Full Text] [Related]
14. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases. Nisijima K; Ishiguro T J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156 [TBL] [Abstract][Full Text] [Related]
15. [Depressive syndromes within the scope of schizophrenic diseases]. Heim M Psychiatr Neurol Med Psychol (Leipz); 1986 Dec; 38(12):716-21. PubMed ID: 3575544 [TBL] [Abstract][Full Text] [Related]
16. [Opinions on psychiatric diseases of the citizens of Novosibirsk: results of a representative study]. Angermeyer MC; Kenzine DV; Korolenko TP; Beck M; Matschinger H Psychiatr Prax; 2004 Mar; 31(2):90-5. PubMed ID: 14983397 [TBL] [Abstract][Full Text] [Related]
17. [Antidepressant treatment of schizophrenic patients]. Caroli F; Baldacci-Epinette C; Ribeyre P Encephale; 1993 Jul; 19 Spec No 2():393-6. PubMed ID: 7904237 [TBL] [Abstract][Full Text] [Related]